Tumor Blood Testing Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Tumor Blood Testing Market Report 2026

Name: Tumor Blood Testing Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Test Type (Circulating Tumor Cells (CTC) Tests, Circulating Tumor DNA (CtDNA) Tests, Exosome-Based Tests, Other Test Types), By Technology (Polymerase Chain Reaction (PCR)-Based Testing, Next-Generation Sequencing, Immunoassays), By Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Melanoma), By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Tumor Blood Testing Market Overview

• Tumor Blood Testing market size has reached to $5.98 billion in 2025

• Expected to grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%

• Growth Driver: Rise In Cancer Prevalence Driving The Growth Of The Market Due To Increasing Demand For Early Detection And Improved Patient Outcomes

• Market Trend: Focus On Non-Invasive Liquid Biopsy Technologies Driving Innovation And Efficiency In The Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tumor Blood Testing Market?

Tumor blood testing is a diagnostic technique that examines a blood sample to identify cancer-related biomarkers. It primarily detects genetic material released by tumors, such as circulating tumor DNA (ctDNA), providing a minimally invasive alternative to traditional tissue biopsies for cancer detection and monitoring. This method enables earlier diagnosis, continuous disease monitoring, and more informed treatment decisions.

The main types of tests in the tumor blood testing market are circulating tumor cells (CTC) tests, circulating tumor DNA (CtDNA) tests, exosome-based tests, and others. Circulating tumor cells (CTC) tests refer to diagnostic tests that detect and analyze cancer cells that have detached from a primary tumor and are circulating in the bloodstream. The various technologies include polymerase chain reaction (PCR)-based testing, next-generation sequencing, microarray-based testing, mass spectrometry and immunoassays. The various types of cancers tested are breast cancer, colorectal cancer, lung cancer, prostate cancer, and melanoma. The key applications include early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The primary end users are hospitals, diagnostic laboratories, research institutes, and others.

Tumor Blood Testing market report bar graph

What Is The Tumor Blood Testing Market Size and Share 2026?

The tumor blood testing market size has grown rapidly in recent years. It will grow from $5.98 billion in 2025 to $6.78 billion in 2026 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to rise in cancer prevalence, limitations of tissue biopsy, advancements in genomic testing, oncology research funding, demand for non-invasive diagnostics.

What Is The Tumor Blood Testing Market Growth Forecast?

The tumor blood testing market size is expected to see rapid growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to early cancer screening programs, ai-enabled genomic analysis, personalized medicine growth, expansion of companion diagnostics, clinical trial adoption. Major trends in the forecast period include liquid biopsy adoption, multi-cancer early detection, minimal residual disease monitoring, personalized oncology testing, high-sensitivity biomarker detection.

Book your 30 minutes free consultation with our research experts

Global Tumor Blood Testing Market Segmentation

1) By Test Type: Circulating Tumor Cells (CTC) Tests, Circulating Tumor DNA (CtDNA) Tests, Exosome-Based Tests, Other Test Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based Testing, Next-Generation Sequencing, Immunoassays

3) By Cancer Type: Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Melanoma

4) By Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Circulating Tumor Cells Tests: Isolation Of Tumor Cells, Enumeration Of Tumor Cells, Characterization Of Tumor Cells

2) By Circulating Tumor DNA Tests: Mutation Detection Of Tumor DNA, Methylation Analysis Of Tumor DNA, Copy Number Variation Analysis Of Tumor DNA, Fragmentation Analysis Of Tumor DNA

3) By Exosome-Based Tests: Protein Profiling Of Exosomes, RNA Profiling Of Exosomes, Lipid Profiling Of Exosomes, Surface Marker Analysis Of Exosomes

4) By Other Tests: Circulating RNA Tests, Tumor Educated Platelet Tests, Protein Biomarker Panels, Multiomics Blood Tests, Immuno Oncology Biomarker Tests

What Is The Driver Of The Tumor Blood Testing Market?

The increasing prevalence of cancer is expected to drive the growth of the tumor blood testing market in the coming years. Aging populations and exposure to risk factors such as poor diet, smoking, and pollution are contributing to a higher incidence of cancer, fueling demand for early detection methods. Tumor blood testing provides a minimally invasive approach to detect cancer before symptoms appear by identifying biomarkers in the bloodstream. This enables timely diagnosis, early treatment, improved patient outcomes, and ongoing monitoring of disease progression and therapy effectiveness. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, as of January 2022, the United States had an estimated 18.1 million cancer survivors, with projections expected to reach 26 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the tumor blood testing industry.

Key Players In The Global Tumor Blood Testing Market

Major companies operating in the tumor blood testing market are Bio-Techne Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Natera Inc., Myriad Genetics Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., Adaptive Biotechnologies Corporation, Freenome Holdings Inc., Grail Inc., Personal Genome Diagnostics Inc., Exosome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems S.p.A.

Global Tumor Blood Testing Market Trends and Insights

Major companies operating in the tumor blood testing market are focusing on developing innovative technology such as, non-invasive liquid biopsy technologies to enable early cancer detection, monitor treatment response, and assess disease progression more efficiently. Non-invasive liquid biopsy technologies are diagnostic tests that detect and analyze cancer-related biomarkers from bodily fluids, providing a safer and more convenient alternative to traditional tissue biopsies. For instance, in February 2024, Delfi Diagnostics, a US-based biotechnology company, in collaboration with Immunocore Holdings plc, a UK-based biotechnology company, launched the DELFI-Tumor Fraction (DELFI-TF) assay, a cancer-monitoring blood test. It analyzes cell-free DNA (cfDNA) fragments in the bloodstream to assess tumor burden and treatment response. This fragmentome-based liquid biopsy offers a non-invasive, cost-effective alternative to traditional methods, requiring minimal plasma and providing results within two weeks.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Tumor Blood Testing Market?

In August 2025, Exact Sciences Corp., a US-based diagnostics and biotechnology company, acquired the rights to a blood-based colon cancer screening test from Freenome Holdings Inc. for an undisclosed amount. Through this acquisition, Exact Sciences Corp aims to strengthen its position in the early cancer detection market and expand its technological capabilities by incorporating Freenome Holdings, Inc.’s advanced multiomics and AI-driven blood testing platform. Freenome Holdings Inc. is a US-based biotechnology company focused on developing blood tests to detect cancer early.

Regional Outlook

North America was the largest region in the tumor blood testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Tumor Blood Testing Market?

The tumor blood testing market consists of revenues earned by entities by providing services such as liquid biopsy testing services, early cancer detection services, clinical trial support services, genetic mutation profiling services, and cancer biomarker screening services. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor blood testing market also includes sales of exosome isolation kits, immunoassay kits, microfluidic devices, epigenetic assay kits, and protein biomarker panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tumor Blood Testing Market Report 2026?

The tumor blood testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tumor blood testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Tumor Blood Testing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$6.78 billion
Revenue Forecast In 2035	$11.13 billion
Growth Rate	CAGR of 13.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Test Type, Technology, Cancer Type, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Bio-Techne Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Natera Inc., Myriad Genetics Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., Adaptive Biotechnologies Corporation, Freenome Holdings Inc., Grail Inc., Personal Genome Diagnostics Inc., Exosome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems S.p.A.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Tumor Blood Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Tumor Blood Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Tumor Blood Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Tumor Blood Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Preventive & Personalized Healthcare

4.2. Major Trends

4.2.1 Liquid Biopsy Adoption

4.2.2 Multi-Cancer Early Detection

4.2.3 Minimal Residual Disease Monitoring

4.2.4 Personalized Oncology Testing

4.2.5 High-Sensitivity Biomarker Detection

5. Tumor Blood Testing Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Oncology Clinics

5.4 Research Institutes

5.5 Pharmaceutical Companies

6. Tumor Blood Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tumor Blood Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Tumor Blood Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Tumor Blood Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Tumor Blood Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Tumor Blood Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tumor Blood Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tumor Blood Testing Market Segmentation

9.1. Global Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Circulating Tumor Cells (CTC) Tests, Circulating Tumor DNA (CtDNA) Tests, Exosome-Based Tests, Other Test Types

9.2. Global Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR)-Based Testing, Next-Generation Sequencing, Immunoassays

9.3. Global Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Melanoma

9.4. Global Tumor Blood Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring

9.5. Global Tumor Blood Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

9.6. Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor Cells Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Isolation Of Tumor Cells, Enumeration Of Tumor Cells, Characterization Of Tumor Cells

9.7. Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor DNA Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mutation Detection Of Tumor DNA, Methylation Analysis Of Tumor DNA, Copy Number Variation Analysis Of Tumor DNA, Fragmentation Analysis Of Tumor DNA

9.8. Global Tumor Blood Testing Market, Sub-Segmentation Of Exosome-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Profiling Of Exosomes, RNA Profiling Of Exosomes, Lipid Profiling Of Exosomes, Surface Marker Analysis Of Exosomes

9.9. Global Tumor Blood Testing Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Circulating RNA Tests, Tumor Educated Platelet Tests, Protein Biomarker Panels, Multiomics Blood Tests, Immuno Oncology Biomarker Tests

10. Tumor Blood Testing Market Regional And Country Analysis

10.1. Global Tumor Blood Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Tumor Blood Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tumor Blood Testing Market

11.1. Asia-Pacific Tumor Blood Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tumor Blood Testing Market

12.1. China Tumor Blood Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tumor Blood Testing Market

13.1. India Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tumor Blood Testing Market

14.1. Japan Tumor Blood Testing Market Overview

14.2. Japan Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tumor Blood Testing Market

15.1. Australia Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tumor Blood Testing Market

16.1. Indonesia Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tumor Blood Testing Market

17.1. South Korea Tumor Blood Testing Market Overview

17.2. South Korea Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tumor Blood Testing Market

18.1. Taiwan Tumor Blood Testing Market Overview

18.2. Taiwan Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tumor Blood Testing Market

19.1. South East Asia Tumor Blood Testing Market Overview

19.2. South East Asia Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tumor Blood Testing Market

20.1. Western Europe Tumor Blood Testing Market Overview

20.2. Western Europe Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tumor Blood Testing Market

21.1. UK Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tumor Blood Testing Market

22.1. Germany Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tumor Blood Testing Market

23.1. France Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tumor Blood Testing Market

24.1. Italy Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tumor Blood Testing Market

25.1. Spain Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tumor Blood Testing Market

26.1. Eastern Europe Tumor Blood Testing Market Overview

26.2. Eastern Europe Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tumor Blood Testing Market

27.1. Russia Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tumor Blood Testing Market

28.1. North America Tumor Blood Testing Market Overview

28.2. North America Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tumor Blood Testing Market

29.1. USA Tumor Blood Testing Market Overview

29.2. USA Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tumor Blood Testing Market

30.1. Canada Tumor Blood Testing Market Overview

30.2. Canada Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tumor Blood Testing Market

31.1. South America Tumor Blood Testing Market Overview

31.2. South America Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tumor Blood Testing Market

32.1. Brazil Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tumor Blood Testing Market

33.1. Middle East Tumor Blood Testing Market Overview

33.2. Middle East Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tumor Blood Testing Market

34.1. Africa Tumor Blood Testing Market Overview

34.2. Africa Tumor Blood Testing Market, Segmentation By Test Type, Segmentation By Technology, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tumor Blood Testing Market Regulatory and Investment Landscape

36. Tumor Blood Testing Market Competitive Landscape And Company Profiles

36.1. Tumor Blood Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Tumor Blood Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Tumor Blood Testing Market Company Profiles

36.3.1. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Tumor Blood Testing Market Other Major And Innovative Companies

Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Natera Inc., Myriad Genetics Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., Adaptive Biotechnologies Corporation, Freenome Holdings Inc., Grail Inc., Personal Genome Diagnostics Inc., Exosome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems S.p.A.

38. Global Tumor Blood Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tumor Blood Testing Market

40. Tumor Blood Testing Market High Potential Countries, Segments and Strategies

40.1 Tumor Blood Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Tumor Blood Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Tumor Blood Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Tumor Blood Testing Market, Overview Of Key Products - Product Examples

Table 2: Global Tumor Blood Testing Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Tumor Blood Testing Market, Supply Chain Analysis

Table 4: Global Tumor Blood Testing Market, Major Raw Material Providers

Table 5: Global Tumor Blood Testing Market, Major Resource Providers

Table 6: Global Tumor Blood Testing Market, Major Manufacturers (Suppliers)

Table 7: Global Tumor Blood Testing Market, Major Distributors And Channel Partners

Table 8: Global Tumor Blood Testing Market, Key Technologies & Future Trends

Table 9: Global Tumor Blood Testing Market, Major Trends

Table 10: Global Tumor Blood Testing Market, Major End Users

Table 11: Global Tumor Blood Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Tumor Blood Testing Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Tumor Blood Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Tumor Blood Testing Market - TAM, US$ Billion, 2025

Table 15: Global Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Tumor Blood Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Tumor Blood Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor Cells Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor DNA Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Tumor Blood Testing Market, Sub-Segmentation Of Exosome-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Tumor Blood Testing Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Tumor Blood Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Tumor Blood Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Tumor Blood Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Tumor Blood Testing Market - Company Scoring Matrix

Table 100: Bio-Techne Corporation Financial Performance

Table 101: Roche Holding AG Financial Performance

Table 102: Thermo Fisher Scientific Inc. Financial Performance

Table 103: Abbott Laboratories Financial Performance

Table 104: Siemens Healthineers AG Financial Performance

Table 105: Global Tumor Blood Testing Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Tumor Blood Testing Market, Competitive Dashboard

Table 107: Global Tumor Blood Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Tumor Blood Testing Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Table 109: Global, Tumor Blood Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 110: Global, Tumor Blood Testing Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

List Of Figures

Figure 1: Global Tumor Blood Testing Market, Overview Of Key Products - Product Examples

Figure 2: Global Tumor Blood Testing Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Tumor Blood Testing Market, Supply Chain Analysis

Figure 4: Global Tumor Blood Testing Market, Major Raw Material Providers

Figure 5: Global Tumor Blood Testing Market, Major Resource Providers

Figure 6: Global Tumor Blood Testing Market, Major Manufacturers (Suppliers)

Figure 7: Global Tumor Blood Testing Market, Major Distributors And Channel Partners

Figure 8: Global Tumor Blood Testing Market, Key Technologies & Future Trends

Figure 9: Global Tumor Blood Testing Market, Major Trends

Figure 10: Global Tumor Blood Testing Market, Major End Users

Figure 11: Global Tumor Blood Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Tumor Blood Testing Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Tumor Blood Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Tumor Blood Testing Market - TAM, US$ Billion, 2025

Figure 15: Global Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Tumor Blood Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Tumor Blood Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor Cells Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor DNA Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Tumor Blood Testing Market, Sub-Segmentation Of Exosome-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Tumor Blood Testing Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Tumor Blood Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Tumor Blood Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Tumor Blood Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Tumor Blood Testing Market - Company Scoring Matrix

Figure 100: Bio-Techne Corporation Financial Performance

Figure 101: Roche Holding AG Financial Performance

Figure 102: Thermo Fisher Scientific Inc. Financial Performance

Figure 103: Abbott Laboratories Financial Performance

Figure 104: Siemens Healthineers AG Financial Performance

Figure 105: Global Tumor Blood Testing Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Tumor Blood Testing Market, Competitive Dashboard

Figure 107: Global Tumor Blood Testing Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Tumor Blood Testing Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030

Figure 109: Global, Tumor Blood Testing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 110: Global, Tumor Blood Testing Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Hemato Oncology Testing Market Report 2026 - Global Outlook – By Product And Services (Assay Kits And Reagents, Services), By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma), By Technology (Polymerase Chain Reaction (...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Blood Screening Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Instruments, Software And Services), By Technology (Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Weste...

Blood Culture Tests Market Report 2026 - Global Outlook – By Method (Conventional/Manual Methods, Automated Methods), By Product (Consumables, Instruments, Software and Services), By Technology (Culture-Based Technology,...

Blood Cancer Drugs Market Report 2026 - Global Outlook – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan Or Mabthera (Rituximab), Gleevec Or Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), ...

Circulating Tumor Cells Market Report 2026 - Global Outlook – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Application (Clini...

Hematocrit Test Devices Market Report 2026 - Global Outlook – By Product (Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables), By Application (Anemia, Polycythemia Vera, Congenital Heart Diseases, ...

Frequently Asked Questions

How big is the Tumor Blood Testing Market?

The Tumor Blood Testing market was valued at $5.98 billion in 2025, increased to $6.78 billion in 2026, and is projected to reach $11.13 billion by 2030.

What is the Tumor Blood Testing market growth?

The global Tumor Blood Testing market is expected to grow at a CAGR of 13.2% from 2026 to 2035 to reach $11.13 billion by 2035.

Who are the key players in Tumor Blood Testing market?

Some Key Players in the Tumor Blood Testing market Include, Bio-Techne Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Natera Inc., Myriad Genetics Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., Adaptive Biotechnologies Corporation, Freenome Holdings Inc., Grail Inc., Personal Genome Diagnostics Inc., Exosome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems S.p.A. .

What is the anticipated growth trend for the Tumor Blood Testing market?

Major trend in this market includes: Focus On Non-Invasive Liquid Biopsy Technologies Driving Innovation And Efficiency In The Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Tumor Blood Testing market?

North America was the largest region in the tumor blood testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor blood testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.